Remarkable differences: the course of life of young adults with galactosaemia and PKU

  • A. M. Bosch
  • H. Maurice-Stam
  • F. A. Wijburg
  • M. A. Grootenhuis


Although the need for insight in factors influencing the quality of life of patients with an inborn error of metabolism is recognized, psychological adjustment of adults with metabolic diseases has not been properly studied. Adult patients with PKU were demonstrated not to differ from healthy controls in terms of their course of life (CoL) and health-related quality of life (HRQoL). However, adults with galactosaemia had a lower HRQoL with significant lower scores on the domains of cognitive and social function. This study investigated the CoL and the social demographical outcomes in these young adults with galactosaemia, and compared them with the general population and with PKU patients. A total of 15 (88%) adult patients with classical galactosaemia participated in this study. Classical galactosaemia patients had a delayed social and psychosexual development compared to their peers from the general population and to PKU patients. Also, they were significantly less frequently married or living together and significantly less frequently employed than the general population. Our study shows a stark contrast between patients with galactosaemia and patients with PKU, although both are diagnosed in the neonatal period and need life-long dietary restrictions. The observed difference is likely due to the long-term somatic complications frequently seen in galactosaemia and thus not due to the burden of a chronic disease necessitating life-long dietary restrictions. We conclude that it is essential that parents and clinicians encourage children with galactosaemia to participate in peer-related activities in order to stimulate social performance, which may result in a more normal CoL.



course of life


course of life questionnaire


health related quality of life




  1. Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF (2004) Living with classical galactosemia, health related quality of life consequences. Pediatrics 113(5):e423–428CrossRefPubMedGoogle Scholar
  2. Bosch AM, Ijlst L, Oostheim W et al (2005) Identification of novel mutations in classical galactosemia. Hum Mutat 25(5):502CrossRefPubMedGoogle Scholar
  3. Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30(1):29–34CrossRefPubMedGoogle Scholar
  4. Cohen J (1988) Statistical power analysis for the behavioral sciences. New York: Academy PressGoogle Scholar
  5. Garber J (1984) Classification of childhood psychopathology: a developmental perspective. Child Dev 55:30–48CrossRefPubMedGoogle Scholar
  6. Gassio R, Artuch R, Vilaseca MA et al (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a pediatric population. Dev Med Child Neurol 47:443–448CrossRefPubMedGoogle Scholar
  7. Grootenhuis MA, Stam H, Destrée-Vonk A, Heijmans HSA, Last BF (2003) Levensloop Vragenlijst voor Jong-Volwassenen. [Course of life questionnaire for young adults]. Gedrag Gezond 31:336–350Google Scholar
  8. Lambert C, Boneh A (2004) The impact of galactosemia on quality of life—a pilot study. J Inherit Metab Dis 27(5):601–608CrossRefPubMedGoogle Scholar
  9. Last BF, Grootenhuis MA, Destrée-Vonk A, Heymans HSA (2000) De ontwikkeling van een levensloopvragenlijst voor jong-volwassenen (LVJV). [The development of a course of life questionnaire for young adults]. Gedrag Gezond 8:22–30Google Scholar
  10. Lewis M, Miller SM (1990) Handbook of developmental psychopathology. New York: Plenum PressGoogle Scholar
  11. Lundstedt G, Johansson A, Melin L, Alm J (2001) Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr 90:1147–1152CrossRefPubMedGoogle Scholar
  12. Schweitzer S, Shin Y, Jacobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosemia. Eur J Paediatr 152:36–43CrossRefGoogle Scholar
  13. Stam H, Grootenhuis MA, Last BF (2005). The course of life of survivors of childhood cancer. Psychooncology 14:227–238CrossRefPubMedGoogle Scholar
  14. Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosemia: Results of a survey of 350 cases. J Inherit Metab Dis 13:802–818CrossRefPubMedGoogle Scholar
  15. Weglage J, Funders B, Wilken B et al (1992) Psychosocial and social findings in adolescents with phenylketonuria. Eur J Paediatr 151:522–525CrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2009

Authors and Affiliations

  • A. M. Bosch
    • 1
  • H. Maurice-Stam
    • 2
  • F. A. Wijburg
    • 1
  • M. A. Grootenhuis
    • 2
  1. 1.Department of PediatricsAcademic Medical Center, University of AmsterdamAmsterdamThe Netherlands
  2. 2.Pediatric Psychosocial DepartmentAcademic Medical Center, University of AmsterdamAmsterdamThe Netherlands

Personalised recommendations